Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Top 20 Immunology Companies of 2026
Shots: 20. Incyte Immunology Segment Revenue: $0.82B Founded Year: 2002 Market Cap: $23.3B Total Employees: 2,800 Headquarters: Delaware, United States Stock Exchange: NASDAQ 19. Organon & Co. (Sun Pharma) Immunology Segment Revenue: $0.95B Founded Year: 2020 Market Cap: N/A Total Employees: 4,000 Headquarters: New Jersey, United States Stock Exchange: NYSE 18. Astellas Immunology Segment Revenue: $1.28B Founded Year: 1923 Market Cap: $23.97B Total Employees: 14,099 Headquarters: Tokyo, Japan … The post Top 20 Immunology Companies of 2026 appeared first on PharmaShots.
Read Full Article
Express Pharma
Indian-origin pharma scientist Dr Rudrangi elected IChemE Fellow
Olema Oncology executive receives Fellowship of the Institution of Chemical Engineers for contributions to chemical engineering and pharmaceutical manufacturing. The post Indian-origin pharma scientist Dr Rudrangi elected IChemE Fellow appeared first on Express Pharma.
Read Full Article
Pharma Tech
Bayer’s heart failure drug bound for NHS on NICE recommendation
Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.
Read Full Article
Pharma Tech
FDA grants traditional approval to Novartis’ Fabhalta for IgAN
The FDA has issued traditional approval to Novartis for Fabhalta to slow the decline of kidney function in adults with primary IgAN who are at risk of disease progression.
Read Full Article
Pharma Tech
MSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD has outpaced rivals to market the first PCSK9 inhibitor in pill form for patients with high cholesterol.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Jul 18, 2026, 2:26 AM
China Medical System to pay Insilico up to $177 million for nervous system work
The two firms will "jointly advance the co-development of the R&D programme", Insilico said.
ET Pharma
Jul 18, 2026, 2:23 AM
Novo Nordisk to launch lower-cost Ozempic copy in South Africa
The medicine, which uses the same semaglutide active ingredient as Ozempic, will launch on July 27 and is registered by the South African Health Products Regulatory Authority (SAHPRA) as the country's only authorised semaglutide copy, the Danish drugmaker said in a statement late on Thursday.
ET Pharma
Jul 18, 2026, 2:21 AM
Goldman Sachs-backed biopharma company Attovia Therapeutics files for US IPO
Founded in 2023, the company develops biologic therapies for immune-mediated diseases using its ATTOBODY platform, with drug candidates targeting inflammatory skin conditions and inflammatory bowel disease.
PharmaShots
Jul 17, 2026, 1:30 PM
Top 20 Immunology Companies of 2026
Shots: 20. Incyte Immunology Segment Revenue: $0.82B Founded Year: 2002 Market Cap: $23.3B Total Employees: 2,800 Headquarters: Delaware, United States Stock Exchange: NASDAQ 19. Organon & Co. (Sun Pharma) Immunology Segment Revenue: $0.95B Founded Year: 2020 Market Cap: N/A Total Employees: 4,000 Headquarters: New Jersey, United States Stock Exchange: NYSE 18. Astellas Immunology Segment Revenue: $1.28B Founded Year: 1923 Market Cap: $23.97B Total Employees: 14,099 Headquarters: Tokyo, Japan … The post Top 20 Immunology Companies of 2026 appeared first on PharmaShots.
PharmaShots
Jul 17, 2026, 12:30 PM
Aqemia Expands Sanofi Collaboration With New Target Nomination
Shots: Ref: Businesswire | Image: Aqemia & Sanofi | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Aqemia Expands Sanofi Collaboration With New Target Nomination appeared first on PharmaShots.
Express Pharma
Jul 17, 2026, 11:49 AM
Indian-origin pharma scientist Dr Rudrangi elected IChemE Fellow
Olema Oncology executive receives Fellowship of the Institution of Chemical Engineers for contributions to chemical engineering and pharmaceutical manufacturing. The post Indian-origin pharma scientist Dr Rudrangi elected IChemE Fellow appeared first on Express Pharma.
News
Latest industry coverage
Google News
Jul 18, 2026, 8:31 PM
Domestic Demand To Drive Indian Pharma Growth In FY27: Report - BW Businessworld
Domestic Demand To Drive Indian Pharma Growth In FY27: Report BW Businessworld
Google News
Jul 18, 2026, 8:18 PM
$1.5b deals, MoUs inked at pharma conference - The Express Tribune
$1.5b deals, MoUs inked at pharma conference The Express Tribune
Google News
Jul 18, 2026, 8:00 PM
Supermarket pharmacies are commonplace in the US and the UK. So why don’t we have them here? - Nine.com.au
Supermarket pharmacies are commonplace in the US and the UK. So why don’t we have them here? Nine.com.au
Google News
Jul 18, 2026, 6:07 PM
AstraZeneca Pharma India files BRSR for FY26 - scanx.trade
AstraZeneca Pharma India files BRSR for FY26 scanx.trade
Google News
Jul 18, 2026, 4:07 PM
FG committed to boosting access to affordable locally-made medicines - The Guardian Nigeria News
FG committed to boosting access to affordable locally-made medicines The Guardian Nigeria News
Google News
Jul 18, 2026, 2:04 PM
Clinical-Grade Wearable For Pharma And Biotech Market Forecast Report Featuring Segment Analysis And Strategic Industry - EIN News
Clinical-Grade Wearable For Pharma And Biotech Market Forecast Report Featuring Segment Analysis And Strategic Industry EIN News
Google News
Jul 18, 2026, 1:41 PM
Big Pharma’s $300 Billion Patent Problem Fuels Biotech Deals - VettaFi - Commentaries - Advisor Perspectives
Big Pharma’s $300 Billion Patent Problem Fuels Biotech Deals - VettaFi - Commentaries Advisor Perspectives
Google News
Jul 18, 2026, 12:16 PM
Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies - Business Insider Africa
Ozempic maker launches cheaper copy in Africa’s largest pharma market after court blocks unregistered Ozempic copies Business Insider Africa
Google News
Jul 18, 2026, 11:39 AM
ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings - simplywall.st
ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings simplywall.st
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer